Researchers have identified a novel therapeutic approach to combat one of oncology’s most persistent challenges: drug-resistant cancer cells. The compound UNI418 works by disrupting the DNA repair mechanisms that allow malignant cells to survive standard cancer treatments. When combined with PARP inhibitors, this approach successfully restored treatment sensitivity in previously resistant cancer cell populations. The research represents a fundamental shift in cancer therapy strategy, moving beyond simply inflicting DNA damage to actively preventing cancer cells from repairing that damage. This combination therapy model addresses a critical survival mechanism that enables cancer cells to evade conventional chemotherapy and radiation. The findings suggest that targeting multiple cellular pathways simultaneously may unlock new treatment options for patients whose cancers have developed resistance to standard interventions.
Was this article helpful?
GMJ Brief · Announcement
📰 Read the full article: Scientists Disrupt Cancer Cell DNA Repair to Overcome Drug Resistance →
